US Initiative to Eliminate Racial and Ethnic Disparities in Health: The Impact on the Outcomes of

Niharika Bhatia1, Deep Vakil2, Stavros Zinonos3

  • 1Rutgers Robert Wood Johnson Medical School Piscataway NJ USA.

Insights

The 1998 federal initiative reduced disparities in percutaneous coronary interventions for ST-segment-elevation myocardial infarction patients. Post-1998, mortality decreased across racial groups, with greater improvements seen in the Hispanic population.

Area of Science:

  • Cardiovascular Medicine
  • Health Disparities Research
  • Public Health Policy

Background:

  • Racial and ethnic health disparities remain a significant concern in the United States.
  • A 1998 federal initiative aimed to eliminate these disparities, but its impact on ST-segment-elevation myocardial infarction (STEMI) outcomes was unclear.
  • Understanding treatment access and mortality trends across different racial groups is crucial for effective public health interventions.

Purpose of the Study:

  • To evaluate the impact of the 1998 federal initiative on percutaneous coronary intervention (PCI) use and mortality rates in Black, Hispanic, and White patients with first-time STEMI.
  • To analyze trends in STEMI outcomes from 1994 to 2015, focusing on disparities in treatment and survival.

Main Methods:

  • Analysis of STEMI patient data (1994-2015) from the Myocardial Infarction Data Acquisition System, including 7942 Black, 27,665 Hispanic, and 88,727 White patients.
  • Logistic regression models were used to assess in-hospital mortality, adjusting for demographics, comorbidities, and interventional procedures.
  • Linear regression with a change point analysis at 1998 was employed to evaluate mortality trends before and after the federal initiative.

Main Results:

  • Percutaneous coronary intervention use increased across all racial groups from 1994 to 2015.
  • PCI disparity favoring White patients pre-1998 was significantly reduced post-initiative, reversing in favor of Hispanic patients after 2005.
  • In-hospital mortality showed a downward trend without significant disparity among the three groups after 1998. One-year all-cause and cardiovascular mortality decreased significantly for all groups post-1998, with the most substantial reduction observed in the Hispanic population.

Conclusions:

  • The 1998 federal initiative likely contributed to reducing disparities in PCI utilization for STEMI patients.
  • Significant reductions in both short- and long-term mortality were observed across all racial groups following the initiative.
  • The Hispanic population experienced a more pronounced decrease in mortality, suggesting a positive impact of the initiative on this demographic.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
26
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
14
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
36
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
403
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
38